Related Experiment Video
Updated: Jun 2, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Vitamin D deficiency in a pediatric population with sickle cell disease
Thiago de Souza Vilela1,2, Mauro Fisberg2,3, Gerson Ferrari4,5
1Department of Pediatrics - Division of Pediatric Hematology, Universidade Federal de São Paulo, Sao Paulo, Brazil.
Insights
Vitamin D deficiency is common in children with sickle cell disease, affecting nearly half of those studied. Risk factors include younger age, less sun exposure, and testing during autumn or winter.
Area of Science:
- Pediatric Hematology
- Nutritional Science
- Endocrinology
Background:
- Sickle cell disease (SCD) is a genetic blood disorder associated with numerous complications.
- Vitamin D deficiency is increasingly recognized as a significant health issue in pediatric populations.
- Hypovitaminosis D in pediatric SCD patients may exacerbate clinical outcomes.
Purpose of the Study:
- To determine the prevalence of vitamin D deficiency in pediatric patients with SCD.
- To identify potential risk factors associated with hypovitaminosis D in this cohort.
- To investigate the relationship between vitamin D levels and clinical parameters in children with SCD.
Main Methods:
- A cross-sectional study was conducted on 60 pediatric patients (aged 3-18 years) diagnosed with SCD.
- Serum 25-hydroxyvitamin D (25-OH-D) levels were measured to assess vitamin D status.
- Statistical analyses, including logistic regression and linear regression, were used to identify risk factors.
Main Results:
- The prevalence of vitamin D deficiency (25-OH-D < 20 ng/mL) was 46.7% in the study population.
- Age (p=0.002) and season of blood collection (p=0.005) were significant factors associated with vitamin D deficiency.
- Linear regression revealed associations between vitamin D levels and age, days of sun exposure, and season of assessment.
Conclusions:
- Hypovitaminosis D is highly prevalent among pediatric patients with sickle cell disease.
- Younger age, reduced sun exposure, and testing during autumn/winter are significant risk factors for vitamin D deficiency in this population.
- Addressing vitamin D deficiency may be crucial for improving health outcomes in children with SCD.
Abstract:
Pediatric patients with sickle cell disease and vitamin D deficiency have worse clinical and laboratory outcomes. This study aims to quantify the prevalence of vitamin D deficiency in this population and identify possible risk factors for hypovitaminosis D by performing a cross-sectional study with children aged 3-18 years old with sickle cell disease. Sixty patients were evaluated, with a mean age of 10.80 + 4.21 years. The prevalence of vitamin D deficiency was 46.7% (21.02 ± 8.47 ng/mL). Patients were clustered into two groups regarding vitamin D deficiency (25-OH-D < 20 ng/mL). When comparing groups with and without vitamin D deficiency, age (p = 0.002) and season of 25-OH-D collection (p = 0.005) were statistically significant. Age presented OR 1.23 (95% CI: 1.07; 1.41/p = 0.004), as well as the season of the 25-OH-D collection with OR 5.21 (95% CI: 1.58; 17.14/p = 0.007) for autumn/winter assessment. After linear regression, an association was noted for age (β = -0.80/95% CI: -1.29; -0.320/p = 0.002), days of sun exposure (β = 0.83/95% CI: 0.07; 1.58/p = 0.032), and autumn/winter vitamin D assessment (β = -7.94/95% CI: -12.02; -3.85/p = 0.032). In conclusion, hypovitaminosis D is highly prevalent in this population; meanwhile, age, season of 25-OH-D collection, and days of sunlight exposure appeared as risk factors for deficiency.
More Related Videos
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamins
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Pedigree Analysis
Skeleton and Calcium Homeostasis